SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UPDOG is trending as the community rallies around the joke-meta coin on Solana, enthusiastically spreading the word with their signature call-and-response meme. Active community engagement is focused on its locked and burned liquidity pool and its listing on the Jupiter Strict List. The coin, trading for over a year, is seeing increased discussion around its potential as a millionaire-maker.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to speculation surrounding a Microsoft deal and potential data center expansion, sparking enthusiastic community discussion. Investors are focused on the company's AI infrastructure and potential for further growth in the sector. Chatter includes land acquisitions and potential for securing more big contracts.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU is trending as community members express excitement about the project's growth and potential, highlighting its strong community and ongoing development. Discussion emphasizes the increasing holder count and the various real-world businesses and products associated with the brand. The community's dedication and organic growth are seen as key drivers for the token's future success.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a community debate about its content and recent comments from Elon Musk, who urged users to cancel subscriptions due to concerns about "woke transgender agenda." This has sparked discussions about culture wars, content quality, and the company's overall direction, leading to both calls for boycotts and defense of the platform.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to early talks of a potential foundry partnership with Intel, a move seen as a possible win for both companies. The community is debating the implications of AMD potentially using Intel's manufacturing capabilities, with some viewing it as a strategic move to diversify supply chains and others questioning the long-term impact on competition and innovation. Bullish sentiment remains, with some anticipating a breakout towards $200, while others caution against potential volatility and a possible pullback.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a 'culture coin' with community members emphasizing its potential for real-world utility and borderless transactions. Community messaging frames it as a movement towards freedom, creativity, and empowerment, drawing comparisons to Bitcoin's early promise. Active discussion also points to its availability on Solana via pump.fun.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending downwards amid community discussion about the potential impact of reduced ChatGPT usage and data licensing deals, with some speculating about a possible overvaluation and others pointing to strong institutional ownership as a buying opportunity. The stock's volatility and sensitivity to AI-related news are key talking points, alongside political biases and the platform's future role in AI training. Technical analysis suggests critical support levels are being watched closely for potential rebounds.

Pump.fun

$PUMP is trending as the community focuses on the potential of the $WAGMI community and its integration with the platform, emphasizing organic growth and a shared vision. Some traders are discussing bullish pennant formations and potential breakouts, while others point to the token's correlation with $SOL and the broader meme coin sector.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending amid community excitement around its new branding and mission, with many calling it a movement. The community is closely watching its performance within the Solana and PUMP ecosystems, with associated coins like UPDOG also gaining traction. Discussions highlight strong community vibes and anticipation for potential gains.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending as retail and institutional investors discuss the potential for a short squeeze, noting the high short interest and options activity. Bullish sentiment is fueled by the company's AI-driven drug discovery platform and potential catalysts, while others express concerns over cash burn. Discussions include upcoming clinical data and government interest in AI healthcare.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Welcome to @Cashvisory_India&#39;s Ask Me Anything (AMA)!  We are a SEBI RIA and VC funded fintech, with a mission to get every single Indian to their first investment. 
 
From the lens of long term wealth creation, if you have any burning questions about your current or prospective investments, feel free to drop in your questions.  
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

Chaitanya Gupta

Stocktwits India

ProfitPapi

Rajni Murugan

Ajay

Satvik Tayal

Tanmoy ghosh

Abhudit Greene

Vansh

Anil Kumar

Teekx Dhadda

Ananya Poddar

Shiv Sharma

Prateek

$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P  $UJJIVANSFB.NSE  what to do?

StockTwits For Android 

Info SysO

Sanjay Jain

Have any query on your current or prospective investments? @Cashvisory_India is hosting an AMA and sharing their views on your queries! Go ahead and drop your questions in their comments below 👇 
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

StockTwits Web

Ask The Community

Welcome to @Cashvisory_India's Ask Me Anything (AMA)!  We are a SEBI RIA and VC funded fintech, with a mission to get every single Indian to their first investment. 
 
From the lens of long term wealth creation, if you have any burning questions about your current or prospective investments, feel free to drop in your questions.  
 


This account has been verified as a SEBI Registered Investment Adviser (RIA).

Verified SEBI RIA Account

SEBI Registered Robo-advisor

@Cashvisory_India  
Long term target for $ZOMATO.NSE

Eternal Ltd.

@Cashvisory_India @Cashvisory_India $EMSLIMITED.NSE $JKIL.NSE target

J.Kumar Infraprojects Ltd

EMS Ltd.

anil anu

@Cashvisory_India $HINDPETRO.NSE is good for a swing trade?

StockTwits for iOS

Hindustan Petroleum Corporation Ltd.

Harshala Chavan

@Cg_1999 $Zomato is definitely a good long term prospect but high valuation is a concern. 
 
Positives: 
- Good EPS growth trends and expected to continue at over 40% growth. 
- Robust growth for Blinkit 
- Increase in GOV by 28% in the food delivery business and overall cost reduction. 
 
Hence, we foresee a 20-30% upside in the stock price from current levels over the next year and a half, but with  growth stocks like Zomato, volatility will persist and one needs to be cautious and patient for longer term gains. 
 
Even with current high EPS growth projections, the valuations are not justified. We would wait for dips in the stock price and dollar cost average in the long run.

 $Zomato is definitely a good long term prospect but high valuation is a concern. 
 
Positives: 
- Good EPS growth trends and expected to continue at over 40% growth. 
- Robust growth for Blinkit 
- Increase in GOV by 28% in the food delivery business and overall cost reduction. 
 
Hence, we foresee a 20-30% upside in the stock price from current levels over the next year and a half, but with  growth stocks like Zomato, volatility will persist and one needs to be cautious and patient for longer term gains. 
 
Even with current high EPS growth projections, the valuations are not justified. We would wait for dips in the stock price and dollar cost average in the long run.

@vedavath  
 
For $EMSLIMITED.NSE: We are bullish on the long term prospects. 
 
Positives: 
- Substantial order book that is expected to grow 
- Healthy consistent ROE of 24.14% and ROCE of 32.31% 
- High operating margin of 29.69% 
- PE of 30 as comapred to industry PE of 42 
- Projected revenue growth of 35% for FY25 
- Very low debt for similar companies 
 
We see an upside of at-least 25% in 12-18 months and very good long term growth prospects as infra continues to be in focus in India.

vivek pandya

Sagar Kanojia

: We are bullish on the long term prospects. 
 
Positives: 
- Substantial order book that is expected to grow 
- Healthy consistent ROE of 24.14% and ROCE of 32.31% 
- High operating margin of 29.69% 
- PE of 30 as comapred to industry PE of 42 
- Projected revenue growth of 35% for FY25 
- Very low debt for similar companies 
 
We see an upside of at-least 25% in 12-18 months and very good long term growth prospects as infra continues to be in focus in India.

@Cashvisory_India @Cashvisory_India 
2024 target for cochin shipyard

Sree Shankar

@Cashvisory_India @Cashvisory_India your view on Akums drugs and pharmaceuticals

 your view on Akums drugs and pharmaceuticals

Prajval G

@Cashvisory_India @Cashvisory_India  
$Atgl price Target

ALPHA TECHNOLOGY GROUP LTD

misba khanum

@Cashvisory_India @Cashvisory_India 
I bought 
BEST AGRO LIFE @ 719
CMP - 595 
Qty- 60 
Present loss -7400 .
What is its future? What shall I do? $BESTAGRO.NSE

Best Agrolife Ltd.

Best Agrolife is trending following shareholder meetings where key appointments and re-appointments were approved, along with the release of FY25 results. The community is focused on the company's revenue growth, strategic initiatives, and new product launches, while also noting a recent revision in the company's credit rating. Discussions also cover the agrochemical sector's potential recovery and Best Agrolife's technical chart patterns.

 
I bought 
BEST AGRO LIFE @ 719
CMP - 595 
Qty- 60 
Present loss -7400 .
What is its future? What shall I do? 

Akash shah

@Cashvisory_India what to do with $UJJIVANSFB.NSE holded 1000 share from

Ujjivan Small Finance Bank Limited

@Cashvisory_India @Cashvisory_India 
You view on $TITAGARH.NSE ( I&#39;m looking for more downside till 1400) and $ASIANPAINT.NSE ( for me potential going up for around 3250 or more) and $$KALYANKJIL.NSE 

Thank you in advance

Asian Paints Ltd.

Kalyan Jewellers India Ltd.

Titagarh Rail Systems Ltd.

 ( I'm looking for more downside till 1400) and 

 ( for me potential going up for around 3250 or more) and $$KALYANKJIL.NSE 

Thank you in advance

Shubh Agarwal

@Cashvisory_India @Cashvisory_India from a swing trading perspective, how much should I aim for in a month, I don&#39;t want to hold stocks for too long and I have multiple targets where I offload shares, what would be a realistic strategy to increase my returns?

 from a swing trading perspective, how much should I aim for in a month, I don't want to hold stocks for too long and I have multiple targets where I offload shares, what would be a realistic strategy to increase my returns?

Roopesh R

@Roopesh80 we aren&#39;t swing trading experts. We believe in and implement a long term value investing strategy. So we can&#39;t really help you out here. 
 
The reason for our approach is going with time tested strategies that work with low effort. If you are a full time trader, only then can trading work and it still might not as most traders don&#39;t even beat the indices.

 we aren't swing trading experts. We believe in and implement a long term value investing strategy. So we can't really help you out here. 
 
The reason for our approach is going with time tested strategies that work with low effort. If you are a full time trader, only then can trading work and it still might not as most traders don't even beat the indices.

@harshalachavan7 Swing trading is not our forte. And we will not be in a position to advise.  
 
However, from a longer term perspective: 
 
Upsides:  
- Good dividend yield of 5.33% 
- Annual Net Profit rose 329.43% in the last year, beating industry avg. of 74% 
- PE of 8.5, lower than industry peers 
- Consistent ROCE of 13.9% in the last 3 years 
 
We see a potential upside of 10-20% in the stock in 12-18 months and we expect the sector and company to do well moving ahead.

 Swing trading is not our forte. And we will not be in a position to advise.  
 
However, from a longer term perspective: 
 
Upsides:  
- Good dividend yield of 5.33% 
- Annual Net Profit rose 329.43% in the last year, beating industry avg. of 74% 
- PE of 8.5, lower than industry peers 
- Consistent ROCE of 13.9% in the last 3 years 
 
We see a potential upside of 10-20% in the stock in 12-18 months and we expect the sector and company to do well moving ahead.

@S__k $COCHINSHIP.NSE  
has a promising long-term outlook but comes with significant valuation concerns. 
 
Positives: 
- Order Book: As of Q3 FY24, the order book stands at ₹21,500 crore, with 52% allocated to green vessels. It includes ₹16,064 crore in defense orders and ₹700 crore in ship repair orders 
- Order Pipeline: ₹9,000 crore in potential new orders supports future growth 
- Debt Management: The company is practically debt-free after redeeming ₹100 crore in tax-free bonds 
 
Valuation Concerns: 
- High Valuation: P/E ratio of 82 and PEG ratio of 7.3 
- Sales Growth: Modest growth of 4.21% over the past five years 
- ROE: Low at 12.7% over the last three years 
- Earnings Composition: Includes ₹307 crore of other income 
 
Outlook: 
We are concerned about valuations and would avoid for 2024. Only go in if there are significant corrections.

Cochin Shipyard Ltd

  
has a promising long-term outlook but comes with significant valuation concerns. 
 
Positives: 
- Order Book: As of Q3 FY24, the order book stands at ₹21,500 crore, with 52% allocated to green vessels. It includes ₹16,064 crore in defense orders and ₹700 crore in ship repair orders 
- Order Pipeline: ₹9,000 crore in potential new orders supports future growth 
- Debt Management: The company is practically debt-free after redeeming ₹100 crore in tax-free bonds 
 
Valuation Concerns: 
- High Valuation: P/E ratio of 82 and PEG ratio of 7.3 
- Sales Growth: Modest growth of 4.21% over the past five years 
- ROE: Low at 12.7% over the last three years 
- Earnings Composition: Includes ₹307 crore of other income 
 
Outlook: 
We are concerned about valuations and would avoid for 2024. Only go in if there are significant corrections.

@Prajval_Govin  
 
General disclaimer: IPOs are generally risky as price discovery happens over a period of time. However: 
 
Akums Drugs is the new pharma on the block.   
 
Upsides:  
- In the unlisted market, the company&#39;s shares are trading at a GMP of Rs 170, which translates into a premium of 25% over the issue price.  
- The co has a strong track record, a large clientele, strong R&amp;D resources, and a key position in the pharmaceutical value chain.  
 
Downsides:  
- The company is raising money to prepay or repay debt of parent and subsidiary companies, and to fund working capital needs, hence this might suggest issues with cashflow utilization and optimization, hindering growth in a capex heavy business. 
- Akums Drugs and Pharma reported a profit of 0.79 crore with a revenue of Rs 4,212.21 crore for the year ended on March 31, 2024. 
 
We recommend waiting and watching for now.

  
 
General disclaimer: IPOs are generally risky as price discovery happens over a period of time. However: 
 
Akums Drugs is the new pharma on the block.   
 
Upsides:  
- In the unlisted market, the company's shares are trading at a GMP of Rs 170, which translates into a premium of 25% over the issue price.  
- The co has a strong track record, a large clientele, strong R&D resources, and a key position in the pharmaceutical value chain.  
 
Downsides:  
- The company is raising money to prepay or repay debt of parent and subsidiary companies, and to fund working capital needs, hence this might suggest issues with cashflow utilization and optimization, hindering growth in a capex heavy business. 
- Akums Drugs and Pharma reported a profit of 0.79 crore with a revenue of Rs 4,212.21 crore for the year ended on March 31, 2024. 
 
We recommend waiting and watching for now.

@misba786  
 
$ATGL.NSE shows strong performance but carries a high valuation, which poses potential risks. 
 
Positives: 
- Strong Volume Growth: CNG volumes grew by 24% in Q3 and 21% in the nine-month period. PNG volumes also showed growth, though at a slower rate. 
- Robust Profitability: EBITDA increased by 26% in Q3 and 20% in the nine-month period. PAT also saw strong growth of 16% in Q3 and 15% in the nine-month period. 
 
Concerns: 
- High Valuation: The PE ratio of 145.60 is significantly higher than the industry average of 18.56. 
 
Outlook: 
 
We would currently stay away due to very high valuations

Adani Total Gas Ltd.

 shows strong performance but carries a high valuation, which poses potential risks. 
 
Positives: 
- Strong Volume Growth: CNG volumes grew by 24% in Q3 and 21% in the nine-month period. PNG volumes also showed growth, though at a slower rate. 
- Robust Profitability: EBITDA increased by 26% in Q3 and 20% in the nine-month period. PAT also saw strong growth of 16% in Q3 and 15% in the nine-month period. 
 
Concerns: 
- High Valuation: The PE ratio of 145.60 is significantly higher than the industry average of 18.56. 
 
Outlook: 
 
We would currently stay away due to very high valuations

@SrjSuraj  
 
Ujjivan Small Finance Bank presents a mixed profile with strong dividend yield and profit growth, but some concerns regarding financial ratios and stock performance. 
 
Positives: 
- Profit Growth: The company has delivered an impressive profit growth of 45.0% CAGR over the last 5 years, reflecting strong financial performance. 
- Strong Loan Book Growth: Disbursements grew to INR 5,286 crores in Q1, contributing to a gross loan book of INR 30,069 crores. 
- Increased Institutional Holdings: FII holding increased significantly from 3.48% to 24.68%, and DIIs holding rose from 2.33% to 7.33%. 
- Valuation Metrics: The PE ratio of 6.77 is significantly below the industry average of 12.20. PEG ratio is very low at 0.15. 
 
Concerns: 
- Low Interest Coverage Ratio: The company has a low interest coverage ratio, which may indicate challenges in covering interest expenses with operating income. 
 
Currently it&#39;s a hold rating from us.

  
 
Ujjivan Small Finance Bank presents a mixed profile with strong dividend yield and profit growth, but some concerns regarding financial ratios and stock performance. 
 
Positives: 
- Profit Growth: The company has delivered an impressive profit growth of 45.0% CAGR over the last 5 years, reflecting strong financial performance. 
- Strong Loan Book Growth: Disbursements grew to INR 5,286 crores in Q1, contributing to a gross loan book of INR 30,069 crores. 
- Increased Institutional Holdings: FII holding increased significantly from 3.48% to 24.68%, and DIIs holding rose from 2.33% to 7.33%. 
- Valuation Metrics: The PE ratio of 6.77 is significantly below the industry average of 12.20. PEG ratio is very low at 0.15. 
 
Concerns: 
- Low Interest Coverage Ratio: The company has a low interest coverage ratio, which may indicate challenges in covering interest expenses with operating income. 
 
Currently it's a hold rating from us.

@Akash182  
 
$BESTAGRO.NSE:  
 
Seasonal failures for the company and pricing pressure due to oversupply from China has been affecting business. The company is launching 4 patented products this year and is bullish on this year&#39;s production.  
 
Upsides:  
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3% 
- PE TTM of 13.4 below the industry levels of 37. 
 
Downsides 
- Company has negative cash flow from operations of -128.01. 
- Reducing EPS over the last year. 
 
We are on the fence. So a hold rating currently.

:  
 
Seasonal failures for the company and pricing pressure due to oversupply from China has been affecting business. The company is launching 4 patented products this year and is bullish on this year's production.  
 
Upsides:  
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3% 
- PE TTM of 13.4 below the industry levels of 37. 
 
Downsides 
- Company has negative cash flow from operations of -128.01. 
- Reducing EPS over the last year. 
 
We are on the fence. So a hold rating currently.

@Cashvisory_India 
Holding above 2700levl,is it worth to hold

 hold it

 
Holding above 2700levl,is it worth to hold

 hold it

@Cashvisory_India $BESTAGRO.NSE 
Target and duration?

@S__k We would consider booking profits and offloading.

 We would consider booking profits and offloading.

@Shubh_01 $TITAGARH.NSE We agree there&#39;s more downside. It was fairly overvalued like some of the other railway stocks. So 1 weak quarter can lead to such slides.   
  
The company seems to have a strong hold on the Indian railway production market, it Achieved highest ever turnover last FY and is set to do a CAPEX of earmarked at INR 1,000 crores over the next couple of years.   
  
Upsides:   
- Consistent EPS of 21  
- The company has shown a  a good profit growth of 48.78% and good revenue growth of 23.28% for the Past 3 years  
  
Downsides:  
- High PE TTM of 69  
- Poor operating numbers recently  
  
In the long term the company is pitted to be a strong one in the rail systems industry, however short term buy-sell pressures might make the stock volatile, hence we recommend buying during the dips and staying invested for long.

 We agree there's more downside. It was fairly overvalued like some of the other railway stocks. So 1 weak quarter can lead to such slides.   
  
The company seems to have a strong hold on the Indian railway production market, it Achieved highest ever turnover last FY and is set to do a CAPEX of earmarked at INR 1,000 crores over the next couple of years.   
  
Upsides:   
- Consistent EPS of 21  
- The company has shown a  a good profit growth of 48.78% and good revenue growth of 23.28% for the Past 3 years  
  
Downsides:  
- High PE TTM of 69  
- Poor operating numbers recently  
  
In the long term the company is pitted to be a strong one in the rail systems industry, however short term buy-sell pressures might make the stock volatile, hence we recommend buying during the dips and staying invested for long.

@Akash182 We don&#39;t do price targets. But waiting and watching for the next year could be the course of action.

 We don't do price targets. But waiting and watching for the next year could be the course of action.